Evidence map›Paper›PMID 42294673›Full record

ArticlemBio2026

Ionophore PBT2 as a novel approach to combat antibiotic-resistant

Huiting Chen, Ibrahim M El-Deeb, Chih-Ho Lai, Yu-Tsen Huang, Jessica Poole, Lauren E Hartley-Tassell, Mark von Itzstein, Michael P Jennings, Freda E-C Jen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huiting ChenInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.
Ibrahim M El-DeebInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.ORCID 0000-0002-4729-4662
Chih-Ho LaiDepartment of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.ORCID 0000-0001-7145-784X
Yu-Tsen HuangDepartment of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Jessica PooleInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.
Lauren E Hartley-TassellInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.ORCID 0000-0003-2415-0321
Mark von ItzsteinInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.ORCID 0000-0001-6302-7524
Michael P JenningsInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.ORCID 0000-0002-1027-4684
Freda E-C JenInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.ORCID 0000-0003-0475-7396

Funding

National Health and Medical Research Council 2001210, 2014388, GNT1196520, GNT2026356, GNT2009677
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriIonophoresOxyquinolineAnimalsDisease Models, AnimalDrug Resistance, Multiple, BacterialHumansMiceMicrobial Sensitivity TestsMicrobial ViabilityAnti-Bacterial AgentsIonophoresOxyquinolinedrug repurposingHelicobacter pyloriionophorePBT2

Identifiers

PMID42294673
PMCPMC13343840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.